Skin News and Research

RSS

Medivir, Meda announce agreement to commercialize Medivir’s cold sore product, Xerese

Medivir and Meda today announced an agreement for the commercialization of Medivir’s cold sore product which will be marketed in North America under the trade name Xerese™.

15 Feb 2010

ALCAT Laboratory introduces compatibility testing to over 130 new functional foods and medicinal herbs

Millions of people use herbs and functional foods to treat countless ailments, from hiccups and hemorrhoids, to balance hormones and stimulate libido. They may work well as natural remedies, but are they safe for everyone?

15 Feb 2010

Research findings may open door to new therapeutic strategies for serious health problems

Drugs that target the way cells convert nutrients into energy could offer new approaches to treating a range of conditions including heart attack and stroke. Using a new way to screen for potential drugs, a team led by Massachusetts General Hospital (MGH) researchers has identified several FDA-approved agents, including an over-the-counter anti-nausea drug, that can shift cellular energy metabolism processes in animals.

15 Feb 2010

People can take simple steps to minimize risk of exposure to allergens during gardening, AAAAI

The beauty of budding plants and bouquet of aromas are sources of satisfaction for many gardeners. For allergy sufferers, though, gardening can be as much a chore as pursuit of passion.

15 Feb 2010

Antibiotics program of Giant Eagle results in more than $3M in free prescriptions for customers

Pittsburgh-based food and fuel retailer Giant Eagle, Inc. launched its free antibiotics program in September of 2009, and is pleased to announce that the program has resulted in more than $3 million in free prescriptions for customers in the company's four-state operating area.

15 Feb 2010

Glycotex announces the expansion of patent portfolio in Advanced Wound Healing for GLYC-101

Glycotex, Inc. today announced the expansion of its patent portfolio in Advanced Wound Healing for its product candidate GLYC-101 currently in clinical phase 2 in the United States.

12 Feb 2010

Encouraging results from Circassia's ToleroMune ragweed allergy T-cell vaccine phase II clinical trial

Circassia Ltd, a specialty biopharmaceutical company focused on allergy, today announced that its ToleroMune(R) ragweed allergy T-cell vaccine achieved positive results in a recently completed phase II clinical trial. Ragweed allergy is particularly common in America, where it affects approximately 25% of the population. Circassia's latest clinical results follow two earlier successful phase II studies with the company's T-cell vaccine against cat allergy.

12 Feb 2010

Customer Care department of Murad named finalist for 2010 Stevie Awards

Murad, Inc. announced today that its Customer Care department has been named a finalist for the 2010 Stevie Awards for Customer Service Department of the Year. Thanks to high scores received from the judges after a month-long preliminary judging process, Murad is now one of nine finalists selected from a pool of more than 500 nominees.

12 Feb 2010

Additional data from Phase III clinical trial of taliglucerase alfa in patients with Gaucher disease presented

Protalix BioTherapeutics, Inc., announced today that additional data from the Company's pivotal Phase III clinical trial of taliglucerase alfa in patients with Gaucher disease was presented at the Annual Meeting of the Lysosomal Disease Network: WORLD Symposium 2010 in Miami, Florida, during an oral session titled, "Novel Enzyme Replacement Therapy for Gaucher Disease: Phase III Pivotal Clinical Trial with Plant Cell Expressed Recombinant Glucocerebrosidase (prGCD) - taliglucerase alfa."

12 Feb 2010

Mayo Clinic provides treatment options for aging skin

Age or liver spots -- These flat, brown areas, also called solar lentigos, typically occur on the hands, back and face. Using a topical retinoid -- often in conjunction with bleaching cream and a mild topical steroid -- may gradually fade an age spot.

11 Feb 2010

Nurse files anonymous complaint with medical board against doctor: Jury hears evidence over misuse of complaint process

Today a jury in West Texas is hearing evidence that a nurse, acting in bad faith, tried to run a doctor out of town by filing an anonymous complaint with the Texas Medical Board. The case is Texas v. Mitchell, No. 5612 (Andrews County, Texas, presiding Judge Jim Rex).

11 Feb 2010

Eczema in early childhood may influence behavior and mental health later in life

Eczema in early childhood may influence behavior and mental health later in life. This is a key finding of a prospective birth cohort study to which scientists of Helmholtz Zentrum München contributed.

11 Feb 2010

Eczema can lead to behavioral and psychological problems in children

11 Feb 2010

Bioactive lipid LPA mediates fibrogenesis in bleomycin mouse model of scleroderma

Amira Pharmaceuticals, Inc. announced today that their collaborators, Andrew Tager, M.D. and Flavia V. Castelino, M.D. of Massachusetts General Hospital, Harvard Medical School, will present a preclinical proof-of-concept study which demonstrates that the bioactive lipid lysophosphatidic acid (LPA), through its high affinity LPA1 receptor, is an important mediator of fibrogenesis in the bleomycin mouse model of scleroderma. Data will be presented as part of a poster session for the 1st Systemic Sclerosis World Congress to be held in Florence, Italy, February 11 to 13, 2010.

11 Feb 2010

CINJ researchers develop new vaccine strategy for pancreatic cancer

More than 42,500 people in the United States were diagnosed with pancreatic cancer last year and nearly 35,200 died from the disease, according to The American Cancer Society.

11 Feb 2010

Drug used to treat parasites in animals may offer new treatment for river blindness, study finds

"Closantel, an older drug used to treat a parasitic liver disease in animals, may prove effective at combating river blindness in humans, a major cause of infection-related blindness, U.S. researchers said on Monday," Reuters reports (Steenhuysen, 2/8).

10 Feb 2010

Candela receives SFDA approval to market its laser systems throughout China

Candela Corporation, a Syneron company, announced today that the SFDA (State Food and Drug Administration) of China has approved the Alex TriVantage® multi-wavelength, Q-switched laser system and the GentleMax® multiple wavelength workstation for sale throughout the People's Republic of China, including Hong Kong.

10 Feb 2010

Study shows more women die of heart disease each year than men

Cardiovascular disease (commonly referred to as heart disease) is the leading cause of death for women worldwide. Almost every minute, a woman in the U.S. dies from heart disease. Despite the prevalence of heart disease in women, a 2005 American Heart Association study showed that 92% of primary care physicians and 83% of cardiologists were not aware of the fact that more women than men die of heart disease each year.

10 Feb 2010

SafeStitch Medical's AMID Stapler receives European CE Mark

SafeStitch Medical, Inc. announced today that it has received CE Mark authorization to commercialize its AMID StaplerTM in the European Economic Community. The new stapler is to be used for fixation of mesh in the repair of hernia defects and also for the approximation of tissues, including skin. The AMID Stapler™ is the first surgical stapler designed specifically for use in inguinal hernia repairs using the Lichtenstein method, in which mesh is implanted for reinforcement. SafeStitch announced in November 2009 that it had received 510(k) clearance from the Food and Drug Administration for sale of the AMID StaplerTM in the U.S. market.

10 Feb 2010

Glissandra Skincare signs first distribution agreement with Enchanted Meadow

Glissandra Skincare™ Inc., dedicated to the research, development, and manufacturing of anti-aging skincare products, announced it has signed its first distributorship agreement granting Enchanted Meadow the rights to distribute Glissandra to its more than 2000 spa and gift industry retailers throughout the US and Canada.

10 Feb 2010

Skin News and Research

Medivir, Meda announce agreement to commercialize Medivir’s cold sore product, Xerese

ALCAT Laboratory introduces compatibility testing to over 130 new functional foods and medicinal herbs

Research findings may open door to new therapeutic strategies for serious health problems

People can take simple steps to minimize risk of exposure to allergens during gardening, AAAAI

Antibiotics program of Giant Eagle results in more than $3M in free prescriptions for customers

Glycotex announces the expansion of patent portfolio in Advanced Wound Healing for GLYC-101

Encouraging results from Circassia's ToleroMune ragweed allergy T-cell vaccine phase II clinical trial

Customer Care department of Murad named finalist for 2010 Stevie Awards

Additional data from Phase III clinical trial of taliglucerase alfa in patients with Gaucher disease presented

Mayo Clinic provides treatment options for aging skin

Nurse files anonymous complaint with medical board against doctor: Jury hears evidence over misuse of complaint process

Eczema in early childhood may influence behavior and mental health later in life

Eczema can lead to behavioral and psychological problems in children

Bioactive lipid LPA mediates fibrogenesis in bleomycin mouse model of scleroderma

CINJ researchers develop new vaccine strategy for pancreatic cancer

Drug used to treat parasites in animals may offer new treatment for river blindness, study finds

Candela receives SFDA approval to market its laser systems throughout China

Study shows more women die of heart disease each year than men

SafeStitch Medical's AMID Stapler receives European CE Mark

Glissandra Skincare signs first distribution agreement with Enchanted Meadow

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News